Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06162611 · ClinicalTrials.gov registry record · Phase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
A Phase 4 study of Emergency Contraception, sponsored by Lori Gawron.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 790
- Enrollment target
- 1
- Study location
NCT06162611 is a Phase 4 study of Emergency Contraception that is actively recruiting participants, run by Lori Gawron. The registered enrollment target is 790 participants, below the 1,442-participant average among 3 other Emergency Contraception trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06162611, a Phase 4 study of Emergency Contraception, is actively recruiting participants, sponsored by Lori Gawron.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 790 participants
- Enrollment target
- 1
- Study location
Study Summary
Intrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This proposal will identify the most effective way to start an implant for emergency contraception using a randomized controlled trial comparing pregnancy risk between those receiving the implant vs. the implant plus oral emergency contraception (EC). Data from this project will inform clinical practice and add another option, the implant, for those desiring a long acting, highly effective contraceptive method when they present for emergency contraception.
Conditions Studied
Interventions
- DRUG Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg
- DEVICE Etonogestrel implant with oral placebo
Study Locations (1)
Utah
- Planned Parenthood Association of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 790 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2028-05-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06162611
The ClinicalTrials.gov registry entry for NCT06162611 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 790 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,442-participant average among 3 other Emergency Contraception trials with a reported enrollment target (45% lower). The listed sponsor is Lori Gawron, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Emergency Contraception appearing as the primary indexed condition, and to 2 interventions - of which Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg is the first listed.
NCT06162611 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06162611 about?
NCT06162611 is a clinical study titled "Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo". Intrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This proposal will identify th...
What is the current status of trial NCT06162611?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 790 participants. The study started on 2023-11-06. Estimated completion is 2028-05-31.
What conditions does trial NCT06162611 study?
This clinical trial studies the following conditions: Emergency Contraception.
What interventions are being tested in trial NCT06162611?
The interventions under investigation include: Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg (DRUG), Etonogestrel implant with oral placebo (DEVICE).
Who is sponsoring clinical trial NCT06162611?
This trial is sponsored by Lori Gawron, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06162611 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergency Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.